Clinical trials of psychedelics creates a patent gold rush
October 25, 2022
A growing number of companies are filing patent applications for natural and synthetic psychedelics encouraged by clinical trials providing evidence that their use may be helpful in treating a wide variety of mental health issues and other medical conditions. Robin Feldman, a professor at the University of California Hastings College of Law, expressed concerns about the gold rush mentality. “It’s not pretty when you look under the hood,” she said. “With psychedelics, what we’re seeing is a clash of cultures between the altruism of those who want to use existing compounds in new and exciting ways crashing up against the realities of the patent system.”
Recent News
Waffle House Workers Strike for Fair Pay and Better Working Conditions
Waffle House workers in Conyers, Georgia, are now on their third day of striking over what they call the company’s unfair policies. Led by the Union of Southern Service Workers (USSW), Waffle House employees are demanding an end to the mandatory “meal credit” deductions from their paychecks, along with better wages and improved working conditions.
Baltimore Bridge Collapse Could Cost Carnival Cruise Line $10M
Carnival Cruise Line revealed that its 2024 earnings could take up to a $10 million hit due to the Baltimore bridge collapse.
Kwik Trip Discontinues Bagged Milk
Bagged milk, a long-standing staple at Kwik Trip, will soon disappear from its shelves.
New England’s Last Coal Plants to Close by 2028
In an agreement reached with the EPA and environmental groups, the last two coal plants in New Hampshire will cease operations in 2025 and 2028, respectively.